Explain this page
Arphra AIPlain-English read on Becton, Dickinson and Company’s valuationCompany profile
DB · companies + sec_company_profileBecton, Dickinson and Company (BDX) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolBDX
- Legal nameBecton, Dickinson and Company
- SectorHealthcare
- IndustryMedical - Instruments & Supplies
- CountryUS
- CurrencyUSD
- ExchangeNYSE
- CIK0000010795
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$54.09B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge market-data, SEC, and non-US sources.
- FIGIBBG000BCZYD3
- CountryUSA
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| Thomas E. Polen Jr. | President, Chief Executive Officer & Chairman | $3.59M | 1973 | — |
| Michael C. Feld | Executive VP & Chief Revenue Officer | $1.91M | 1981 | — |
| Richard Byrd | Executive Vice President & President of Interventional Segment | $1.41M | 1968 | — |
| Michael Garrison | Executive VP & President of Medical Segment and BioPharma Systems Segments | $1.36M | 1969 | — |
| Pamela L. Spikner | Senior Vice President, Chief Accounting Officer & Controller | — | 1977 | — |
| Shawn C. Bevec | Senior Vice President of Investor Relations | — | — | — |
| Claudia Curtis | Senior Vice President, Chief Ethics & Compliance Officer | — | — | — |
| Vitor Roque | Senior VP of Business Finance & Interim CFO | — | 1983 | — |